Methods to Compare Adverse Events in Twitter to FAERS, Drug Information Databases, and Systematic Reviews: Proof of Concept with Adalimumab
- PMID: 30167992
- PMCID: PMC6223697
- DOI: 10.1007/s40264-018-0707-6
Methods to Compare Adverse Events in Twitter to FAERS, Drug Information Databases, and Systematic Reviews: Proof of Concept with Adalimumab
Abstract
Introduction: Adverse drug reactions (ADRs) are associated with significant health-related and financial burden, and multiple sources are currently utilized to actively discover them. Social media has been proposed as a potential resource for monitoring ADRs, but drug-specific analytical studies comparing social media with other sources are scarce.
Objectives: Our objective was to develop methods to compare ADRs mentioned in social media with those in traditional sources: the US FDA Adverse Event Reporting System (FAERS), drug information databases (DIDs), and systematic reviews.
Methods: A total of 10,188 tweets mentioning adalimumab collected between June 2014 and August 2016 were included. ADRs in the corpus were extracted semi-automatically and manually mapped to standardized concepts in the Unified Medical Language System. ADRs were grouped into 16 biologic categories for comparisons. Frequencies, relative frequencies, disproportionality analyses, and rank ordering were used as metrics.
Results: There was moderate agreement between ADRs in social media and traditional sources. "Local and injection site reactions" was the top ADR in Twitter, DIDs, and systematic reviews by frequency, ranked frequency, and index ranking. The next highest ADR in Twitter-fatigue-ranked fifth and seventh in FAERS and DIDs.
Conclusion: Social media posts often express mild and symptomatic ADRs, but rates are measured differently in scientific sources. ADRs in FAERS are reported as absolute numbers, in DIDs as percentages, and in systematic reviews as percentages, risk ratios, or other metrics, which makes comparisons challenging; however, overlap is substantial. Social media analysis facilitates open-ended investigation of patient perspectives and may reveal concepts (e.g. anxiety) not available in traditional sources.
Conflict of interest statement
Karen Smith, Su Golder, Abeed Sarker, Yoon Loke, Karen O’Connor, and Graciela Gonzalez-Hernandez have no conflicts of interest that are directly relevant to the contents of this study. After the commencement of this study, Graciela Gonzalez-Hernandez received funding from AbbVie Inc. for an unrelated research project focusing on using social media to complement pregnancy registry information. AbbVie or its employees had no influence on or knowledge of the design, methodology, or findings discussed in this paper.
Figures
Similar articles
-
Complementing the US Food and Drug Administration Adverse Event Reporting System With Adverse Drug Reaction Reporting From Social Media: Comparative Analysis.JMIR Public Health Surveill. 2020 Sep 30;6(3):e19266. doi: 10.2196/19266. JMIR Public Health Surveill. 2020. PMID: 32996889 Free PMC article.
-
A Comparative View of Reported Adverse Effects of Statins in Social Media, Regulatory Data, Drug Information Databases and Systematic Reviews.Drug Saf. 2021 Feb;44(2):167-179. doi: 10.1007/s40264-020-00998-1. Epub 2020 Oct 1. Drug Saf. 2021. PMID: 33001380 Free PMC article.
-
Detection of Adverse Drug Reactions using Medical Named Entities on Twitter.AMIA Annu Symp Proc. 2018 Apr 16;2017:1215-1224. eCollection 2017. AMIA Annu Symp Proc. 2018. PMID: 29854190 Free PMC article.
-
Utilizing social media data for pharmacovigilance: A review.J Biomed Inform. 2015 Apr;54:202-12. doi: 10.1016/j.jbi.2015.02.004. Epub 2015 Feb 23. J Biomed Inform. 2015. PMID: 25720841 Free PMC article. Review.
-
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217. Cochrane Database Syst Rev. 2022. PMID: 36321557 Free PMC article.
Cited by
-
Comparison of drug safety data obtained from the monitoring system, literature, and social media: An empirical proof from a Chinese patent medicine.PLoS One. 2019 Nov 6;14(11):e0222077. doi: 10.1371/journal.pone.0222077. eCollection 2019. PLoS One. 2019. PMID: 31693665 Free PMC article.
-
The Value of Social Media Analysis for Adverse Events Detection and Pharmacovigilance: Scoping Review.JMIR Public Health Surveill. 2024 Sep 6;10:e59167. doi: 10.2196/59167. JMIR Public Health Surveill. 2024. PMID: 39240684 Free PMC article.
-
Psychiatric Adverse Events Associated With Infliximab: A Cohort Study From the French Nationwide Discharge Abstract Database.Front Pharmacol. 2020 Apr 22;11:513. doi: 10.3389/fphar.2020.00513. eCollection 2020. Front Pharmacol. 2020. PMID: 32390850 Free PMC article.
-
Mapping Strategies to Assess and Increase the Validity of Published Disproportionality Signals: A Meta-Research Study.Drug Saf. 2023 Sep;46(9):857-866. doi: 10.1007/s40264-023-01329-w. Epub 2023 Jul 8. Drug Saf. 2023. PMID: 37421568 Free PMC article.
-
Mild Adverse Events of Sputnik V Vaccine in Russia: Social Media Content Analysis of Telegram via Deep Learning.J Med Internet Res. 2021 Nov 29;23(11):e30529. doi: 10.2196/30529. J Med Internet Res. 2021. PMID: 34662291 Free PMC article.
References
-
- Kongkaew C, Noyce PR, Ashcroft DM. Hospital admissions associated with adverse drug reactions: a systematic review of prospective observational studies. Ann Pharmacother. 2008;42(7):1017–1025. - PubMed
-
- FDA Adverse Event Reporting System (FAERS). http://www.fda.gov/Drugs/InformationOnDrugs/ucm135151.htm. Accessed 6 Jan 2016.
-
- Heinrich J. Adverse drug events: Substantial problem but magnitude uncertain: United States General Accounting Office; 2000. p. 6. http://www.gao.gov/new.items/he00053t.pdf. Accessed 10 Aug 2018.
-
- World Health Organization. Safety of medicines—a guide to detecting and reporting adverse drug reactions—why health professionals need to take action: World Health Organization; 2017. http://apps.who.int/medicinedocs/en/d/Jh2992e/3.html. Accessed Apr 2017.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials